To analyze lymphoid populations within the tumor from one patient (patient 4), the fresh tumor tissue was finely minced with scissors and filtered through a nylon membrane, and a single-cell suspension was purified over a Ficoll–Hypaque density gradient. Cells were stained with the following anti-human antibodies: anti-αβTCR (IP26, eBioscience, San Diego, CA, USA),
anti-CD8 (OKT8, eBioscience),
anti-CD44 (IM7, eBioscience),
anti-PD-1 (eBioJ105, eBioscience), anti-CD27 (O323, eBioscience), anti-CD20 (2H7, eBioscience), anti-CD1c (L161, eBioscience), anti-γδTCR (B1, BioLegend, San Diego, CA, USA),
anti-CD4 (OKT4, BioLegend),
anti-CD28 (CD28.2, BioLegend), anti-FAS (DX2, BioLegend),
anti-ICOS (C398.4A, BioLegend), anti-IgM (MHM-88, BioLegend), anti-CD21 (B-ly4, BD Biosciences, San Jose, CA, USA), anti-CD23 (M-L233, BD Biosciences), and
anti-IgD (Southern Biotech, Birmingham, AL, USA). Flow cytometry was performed using a
BD FACS Canto II flow cytometer (BD Biosciences) and analyzed via FlowJo software (Tree Star, Ashland, OR, USA).
Lee H.W., Lee H., Park C., Oh W.J., Kim T.J., Kwon G.Y, & Seo S.I. (2021). Pattern of Tumor-Infiltrating Lymphocytes in Mixed Epithelial and Stromal Tumor of the Kidney: A Review of Five Cases. Cells, 10(4), 917.